1Kawasaki T. Pediatric acute febrile rnueocutancous lymph node ayndrome with characteristic desquamation of fingers and toes: my clinical observation of fifty cases [J]. Japanese Journal of Allergy, 1967, 16 (3): 178.
5Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, treatment, and long - term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the young, American Heart Association [J]. Pediatrics, 2004, 114 (6): 1708.
10Egami K, Muta H, lshii M et al. Prediction of resistanse to intravenous immnoglobin treatment in patients with Kawasaki disease [J]. J Pediatr, 2006, 149 (2): 237.
5Iemure M, Ishii M, Sugimura T, et al. Long consequences of regressed coronary aneurysms after Kawasaki disease: Vascular wall morphology and function[J]. Heart ,2000,83 ( 3 ) :307-311.
6Meissner HC, Leung DY. Superantigens, conventional antigens and the etiology of Kawasaki syndrome [J]. Pediatr Infect Dis J ,2000,19 (2) :91.
7Onouchi Y,Ozaki K,Burns JC. A genome-wide association study identifies three new risk loci for Kawasaki disease[J].Nature genetics,2012,(05):517-521.
8Kim JJ,Hong YM,Sohn S. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease[J].Human Genetics,2011,(05):487-495.
9沈映君.中药药理学[M].第2版.北京:人民卫生出版社,2010:391-393,673.
10Kim JY, Kim HJ. A case of kawasaki disease with coro- nary aneurysm responding to the 4th IVIG treatment[J]. Case Rep Cardiol,2014:821812.
